Final Patient Completes Prosonix’ Phase 2 Clinical Study with PSX1002

News   Aug 19, 2013

 
Final Patient Completes Prosonix’ Phase 2 Clinical Study with PSX1002
 
 
 

RELATED ARTICLES

Novel Green Chemistry Method Improves Pharmaceutical Manufacturing Efficiency

News

About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient - but not both. Researchers have now developed a green chemistry method that combines aspects of both processes to improve efficiency at a minimal cost of processing time.

READ MORE

Enamine and BioSolveIT Launch the World's Largest Searchable Chemical Space for Novel Compound Sourcing

News

REAL Space Navigator offers access to over 640 million pharma-oriented compounds.

READ MORE

Lonza to Establish Cell- and Gene-Therapy Centers of Excellence to Accelerate Growth

News

Lonza will establish Centers of Excellence for Cell and Gene Therapy to support and accelerate the growth of this priority area for the company.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE